This project is part of the EDCTP2 Programme supported by the European Union.

Resources

Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study

The Lancet infectious diseases

Peer reviewed article